Evidence map›Paper›PMID 27289094›Full record

ArticleGenome biology and evolution2016

Whole-Genome Comparative Analysis of Two Carbapenem-Resistant ST-258 Klebsiella pneumoniae Strains Isolated during a North-Eastern Ohio Outbreak: Differences within the High Heterogeneity Zones.

María Soledad Ramirez, Gang Xie, German M Traglia, Shannon L Johnson, Karen W Davenport, David van Duin, Azam Ramazani, Federico Perez, Michael R Jacobs, David J Sherratt and 3 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology and evolution, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Carbapenemases: TransformingBiomolecules · 2020
    Review
  5. SmallFrontiers in microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 3 countries.

María Soledad RamirezCenter for Applied Biotechnology Studies, Department of Biological Science, California State University Fullerton, Fullerton, CA.
Gang XieBioscience Division Los Alamos National Laboratory, Los Alamos, NM.
German M TragliaIMPaM (UBA-CONICET), University of Buenos Aires, Buenos Aires, Argentina.
Shannon L JohnsonBioscience Division Los Alamos National Laboratory, Los Alamos, NM.
Karen W DavenportBioscience Division Los Alamos National Laboratory, Los Alamos, NM.
David van DuinDivision of Infectious Diseases, University of North Carolina, Chapel Hill, NC.
Azam RamazaniCenter for Applied Biotechnology Studies, Department of Biological Science, California State University Fullerton, Fullerton, CA Department of Biochemistry, University of Oxford, United Kingdom.
Federico PerezLouis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH.
Michael R JacobsDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH.
David J SherrattDepartment of Biochemistry, University of Oxford, United Kingdom.
Robert A BonomoLouis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH.
Patrick S G ChainIMPaM (UBA-CONICET), University of Buenos Aires, Buenos Aires, Argentina.
Marcelo E TolmaskyCenter for Applied Biotechnology Studies, Department of Biological Science, California State University Fullerton, Fullerton, CA mtolmasky@fullerton.edu.
California State University, Fullerton · USLos Alamos National Laboratory · USUniversity of Buenos Aires · ARCase Western Reserve University · USLouis Stokes Cleveland VA Medical Center · USUniversity of North Carolina at Chapel Hill · USUniversity of Oxford · GBUniversity School · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Institutional Career Development CoreKL2TR001862 · NCATS · YALE UNIVERSITY · PI CANTLEY, LLOYD G, EDELMAN, E. JENNIFER · 2016 to 2025
$12.2M
Minority Health and Health Disparities International Research Training ProgramT37MD001368 · NIMHD · CALIFORNIA STATE UNIVERSITY FULLERTON · PI TOLMASKY, MARCELO E · 2005 to 2024
$3.9M
DEALING WITH ANTIBIOTIC RESISTANCE--ANTISENSE TECHNOLOGYR15AI047115 · NIAID · CALIFORNIA STATE UNIVERSITY FULLERTON · PI TOLMASKY, MARCELO E · 2000 to 2022
$1.8M
Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniaeR21AI114508 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A., VAN DUIN, DAVID · 2015 to 2016
$445k
GxE: Monoamine Transporter Genotypes and Risk of Trauma-Related PsychopathologyF32MH083469 · NIMH · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI AMSTADTER, ANANDA B · 2008 to 2008
$42k
NCATS NIH HHS KL2 TR001862NCATS NIH HHS UL1 TR001863NIAID NIH HHS R15 AI047115NIAID NIH HHS R21 AI114508NIMHD NIH HHS T37 MD001368NIMH NIH HHS F32 MH083469Wellcome Trust 200782/Z/16/Z
6 · The paper itself

Abstract

Klebsiella pneumoniae has become one of the most dangerous causative agents of hospital infections due to the acquisition of resistance to carbapenems, one of the last resort families of antibiotics. Resistance is usually mediated by carbapenemases coded for by different classes of genes. A prolonged outbreak of carbapenem-resistant K. pneumoniae infections has been recently described in northeastern Ohio. Most strains isolated from patients during this outbreak belong to MLST sequence type 258 (ST258). To understand more about this outbreak two isolates (strains 140 and 677), one of them responsible for a fatal infection, were selected for genome comparison analyses. Whole genome map and sequence comparisons demonstrated that both strains are highly related showing 99% average nucleotide identity. However, the genomes differ at the so-called high heterogeneity zone (HHZ) and other minor regions. This study identifies the potential value of the HHZ as a potential marker for K. pneumoniae clinical and epidemiological studies.

Indexed as

Anti-Bacterial AgentsCarbapenemsCross InfectionDisease OutbreaksDrug Resistance, BacterialGenetic HeterogeneityGenome, BacterialHumansKlebsiella InfectionsKlebsiella pneumoniaeAnti-Bacterial AgentsCarbapenemscarbapenemKPCoptical mapST-258whole genome mapping

Identifiers

PMID27289094
PMCPMC4943203
OpenAlexW2413281848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.